Jade Biosciences, Inc. (JBIO)

JBIO · BiotechSign Pipeline

Pipeline Overview

Therapeutic Focus: Biotech / Pharmasrc

Signal Snapshot

Clinical Trials (ClinicalTrials.gov aggregate)

Catalyst Records

Publication on Record

3 Phase 1, 1 Phase 2

Trial Phase Mix

ClinicalTrials.gov aggregate as of 2026-09-29. Source

Recent Publications

Simulating real-world abrocitinib use in atopic dermatitis: results from JADE REAL. — J Dermatolog Treat (2026) PMID 42565345

Get real-time catalyst alerts, analyst signals, dilution risk scores, and full pipeline data for Jade Biosciences, Inc..

Full JBIO Data Sign Up Free

Primary Sources

Company identity
Therapeutic indication
Clinical trial aggregate
Publication 42565345

This page reports only records present in the BiotechSign source payload as of the generation date. It does not infer drug efficacy, clinical outcome probability, approval odds, revenue, market size, or unreported regulatory events.